By Leah Douglas and Siddhi Mahatole Feb 6 (Reuters) - The U.S. Food and Drug Administration said on Friday it would take ...

If you double 1 penny every day for 30 days, you would end up with over $5 million. This exponential growth showcases the ...

When a medication doesn’t exist in the right dose, form or formulation, patients are left with few options – a challenge in rural areas like La Plata County. That gap is filled by compounding ...

With online health and wellness company Hims & Hers opening a new front in the GLP-1 compounding showdown Thursday, the ...

Food and Drug Administration targets Hims & Hers after telehealth company undercuts Novo Nordisk on obesity shot ...

While we continue to believe The Trade Desk remains a high-quality business with attractive long-term attributes, our ...

At a starting cost of just $49 per month, the new pills are the cheapest GLP-1 option yet. But experts say compounded drugs ...

The FDA said on Friday it plans to restrict GLP-1 ingredients used in non-approved compounded drugs from companies like Hims & Hers.

Want to become a millionaire by 40? Build these financial habits in your 20s and 30s, from automating your Roth IRA to ...

Novo Nordisk vowed to take legal action against telehealth company Hims & Hers for selling a knockoff of its weight loss pill ...

NEW YORK, Feb 6 (Reuters) - Hims & Hers sent a shockwave through the pharmaceutical industry on Thursday with its ...

Hims Hers Health Inc (NYSE:HIMS) shares plummeted 12.6% in after-hours trading Friday following a stark warning from federal ...